These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12848409)

  • 21. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
    Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
    Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
    Taylor A; Goldberg D; Hutchinson S; Cameron S; Gore SM; McMenamin J; Green S; Pithie A; Fox R
    J Infect; 2000 Mar; 40(2):176-83. PubMed ID: 10841096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia.
    Islam MM; Topp L; Conigrave KM; White A; Haber PS; Day CA
    Int J Drug Policy; 2013 Jul; 24(4):326-32. PubMed ID: 22818978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Needle exchange use among a cohort of injecting drug users.
    Schoenbaum EE; Hartel DM; Gourevitch MN
    AIDS; 1996 Dec; 10(14):1729-34. PubMed ID: 8970694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
    Hutchinson SJ; Wadd S; Taylor A; Bird SM; Mitchell A; Morrison DS; Ahmed S; Goldberg DJ
    Vaccine; 2004 Nov; 23(2):210-4. PubMed ID: 15531039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptance and completion of hepatitis B vaccination among drug users in New York City.
    Ompad DC; Galea S; Wu Y; Fuller CM; Latka M; Koblin B; Vlahov D
    Commun Dis Public Health; 2004 Dec; 7(4):294-300. PubMed ID: 15779793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of 15-19-year-old first attenders at the Dublin Needle Exchange, 1990-97.
    Mullen L; Barry J
    Addiction; 2001 Feb; 96(2):251-8. PubMed ID: 11182870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Universal hepatitis B vaccination: hospital factors influencing first-dose uptake for neonates in Darwin.
    Connors CM; Miller NC; Krause VL
    Aust N Z J Public Health; 1998 Feb; 22(1):143-5. PubMed ID: 9599867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low prevalence, low immunization and low adherence to full hepatitis B vaccine scheme and high-risk behaviors among crack cocaine users in central Brazil.
    da Silva LN; da Silva França DD; Del-Rio NHA; Dos Santos Carneiro MA; Martins RMB; Guimarães RA; Pinheiro RS; Junqueira ALN; Caetano KAA; Teles SA
    J Infect Public Health; 2017; 10(1):76-83. PubMed ID: 27026240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
    Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
    Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'It's your life!': injecting drug users, individual responsibility and hepatitis C prevention.
    Fraser S
    Health (London); 2004 Apr; 8(2):199-221. PubMed ID: 15068637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B vaccination and injecting drug users.
    Budd J; Robertson R; Elton R
    Br J Gen Pract; 2004 Jun; 54(503):444-7. PubMed ID: 15186567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure to vaccinate current injecting drug users against hepatitis B in England and Wales.
    Lamagni TL; Hope VD; Davison KL; Parry JV; Gill ON
    Commun Dis Public Health; 2001 Mar; 4(1):71-2. PubMed ID: 11467026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of specialist drug services to deliver hepatitis B vaccination.
    Morrison DS; Gilchrist G; Ahmed S
    Commun Dis Public Health; 2002 Dec; 5(4):321-3. PubMed ID: 12564250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.